Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
efficacy in a rodent postoperative pain model
Tyr) or insulin receptor-(1155-1165) peptide by 82% and 81%
InChi: InChI=1S/C29H30N2O2/c1-28(2)14-15-29(3
PubMed PMID: 10525088
Molecular Weight: 188
Platensimycin e chloride hydrate efficacy in a rodent postoperativePlatensimycin is an antibiotic produced by S. platensis that inhibits gram positive bacteria by selectively inhibiting cellular lipid biosynthesis (IC50=0. 1 M). Platensimycin targets the ketoacyl acyl carrier protein synthase I II, FabF B, an enzyme that participates in the biosynthesis of fatty acids (IC50s=48 nM and 160 nM for S. aureus and E. coli enzymes, respectively). Platensimycin is a promising agent for overcoming antibiotic resistance.